tetano
Editor, Senior Moderator
Pathogens
. 2021 Nov 11;10(11):1459.
doi: 10.3390/pathogens10111459.
Insights into the SARS-CoV-2-Mediated Alteration in the Stress Granule Protein Regulatory Networks in Humans
Kartikay Prasad[SUP] 1 [/SUP], Abdullah F Alasmari[SUP] 2 [/SUP], Nemat Ali[SUP] 2 [/SUP], Rehan Khan[SUP] 3 [/SUP], Adel Alghamdi[SUP] 2 [/SUP], Vijay Kumar[SUP] 1 [/SUP]
Affiliations
Abstract
The rapidly and constantly evolving coronavirus, SARS-CoV-2, imposes a great threat to human health causing severe lung disease and significant mortality. Cytoplasmic stress granules (SGs) exert anti-viral activities due to their involvement in translation inhibition and innate immune signaling. SARS-CoV-2 sequesters important SG nucleator proteins and impairs SG formation, thus evading the host response for efficient viral replication. However, the significance of SGs in COVID-19 infection remains elusive. In this study, we utilize a protein-protein interaction network approach to systematically dissect the crosstalk of human post-translational regulatory networks governed by SG proteins due to SARS-CoV-2 infection. We uncovered that 116 human SG proteins directly interact with SARS-CoV-2 proteins and are involved in 430 different brain disorders including COVID-19. Further, we performed gene set enrichment analysis to identify the drugs against three important key SG proteins (DYNC1H1, DCTN1, and LMNA) and also looked for potential microRNAs (miRNAs) targeting these proteins. We identified bexarotene as a potential drug molecule and miRNAs, hsa-miR-615-3p, hsa-miR-221-3p, and hsa-miR-124-3p as potential candidates for the treatment of COVID-19 and associated manifestations.
Keywords: SARS-CoV-2; drug; miRNAs; network; protein–protein interaction; stress granule proteins.
. 2021 Nov 11;10(11):1459.
doi: 10.3390/pathogens10111459.
Insights into the SARS-CoV-2-Mediated Alteration in the Stress Granule Protein Regulatory Networks in Humans
Kartikay Prasad[SUP] 1 [/SUP], Abdullah F Alasmari[SUP] 2 [/SUP], Nemat Ali[SUP] 2 [/SUP], Rehan Khan[SUP] 3 [/SUP], Adel Alghamdi[SUP] 2 [/SUP], Vijay Kumar[SUP] 1 [/SUP]
Affiliations
- PMID: 34832615
- DOI: 10.3390/pathogens10111459
Abstract
The rapidly and constantly evolving coronavirus, SARS-CoV-2, imposes a great threat to human health causing severe lung disease and significant mortality. Cytoplasmic stress granules (SGs) exert anti-viral activities due to their involvement in translation inhibition and innate immune signaling. SARS-CoV-2 sequesters important SG nucleator proteins and impairs SG formation, thus evading the host response for efficient viral replication. However, the significance of SGs in COVID-19 infection remains elusive. In this study, we utilize a protein-protein interaction network approach to systematically dissect the crosstalk of human post-translational regulatory networks governed by SG proteins due to SARS-CoV-2 infection. We uncovered that 116 human SG proteins directly interact with SARS-CoV-2 proteins and are involved in 430 different brain disorders including COVID-19. Further, we performed gene set enrichment analysis to identify the drugs against three important key SG proteins (DYNC1H1, DCTN1, and LMNA) and also looked for potential microRNAs (miRNAs) targeting these proteins. We identified bexarotene as a potential drug molecule and miRNAs, hsa-miR-615-3p, hsa-miR-221-3p, and hsa-miR-124-3p as potential candidates for the treatment of COVID-19 and associated manifestations.
Keywords: SARS-CoV-2; drug; miRNAs; network; protein–protein interaction; stress granule proteins.